Rapport Therapeutics, Inc. Common Stock (RAPP) — Financial Flexibility Index
Rapport Therapeutics, Inc. Common Stock (RAPP) has a Financial Flexibility Index of -0.50x as of March 2026. Free cash flow of $-12.97 Million (operating CF $-13.06 Million minus capex $86.00K) represents 0% of total liabilities ($26.09 Million). Check financial resilience of Rapport Therapeutics, Inc. Common Stock to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rapport Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Rapport Therapeutics, Inc. Common Stock across 4 annual periods. See RAPP working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Rapport Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Rapport Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Rapport Therapeutics, Inc. Common Stock stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.13x | $-86.86 Million | $-87.47 Million | $27.78 Million | ▲ +52.4% |
| 2024 | -6.57x | $-62.42 Million | $-64.83 Million | $9.51 Million | ▼ -4554.3% |
| 2023 | -0.14x | $-25.55 Million | $-27.18 Million | $181.06 Million | ▲ +42.3% |
| 2022 | -0.24x | $-2.96 Million | $-3.24 Million | $12.10 Million | — |